KRISTIN HOUSE: Open Payments
NPI 1518235217 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 81 payments from 17 companies in 2025. Trend: 2023 $1,885 · 2024 $1,513 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $362 |
| ABBVIE INC. | 14 | $226 |
| Lilly USA, LLC | 11 | $142 |
| Abbott Laboratories | 6 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $94 |
| Corcept Therapeutics | 4 | $83 |
| SANOFI-AVENTIS U.S. LLC | 3 | $68 |
| PFIZER INC. | 3 | $63 |
| Dexcom, Inc. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
Products named: Ozempic, FREESTYLE LIBRE 3, VRAYLAR, Kerendia, Korlym, Wegovy, TZIELD, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
